Evaluation of the relative cost-effectiveness of treatments for infertility in the UK

Z Philips, Philips Z, Barraza-Llorens M, M Barraza-Llorens, Mariana Barraza-Lloréns, J Posnett, Posnett J, John Posnett
Human Reproduction · 2000 · vol. 15(1) , pp. 95–106 · doi:10.1093/humrep/15.1.95 · PMID:10611196 · W2055559919
Other OA: closed CC0 ⤵ 15 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This paper models the cost-effectiveness of infertility treatments in the UK, finding IVF most cost-effective for severe tubal factors/endometriosis, surgery for mild/moderate disease, medical treatment for ovulatory factors, and IUI for unexplained/male factors.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

This paper aims to complement existing clinical guidelines by providing evidence of the relative cost-effectiveness of treatments for infertility in the UK. A series of decision-analytical models have been developed to reflect current diagnostic and treatment pathways for the five main causes of infertility. Data to populate the models are derived from a systematic review and routine National Health Service activity data, and are augmented with expert opinion. Costs are derived from an analysis of extra-contractual referral tariffs and private sector data. Sensitivity analysis has been carried out to take account of the uncertainty of model parameters and to allow results to be interpreted in the light of local circumstances. Results of the modelling exercise suggest in-vitro fertilization is the most cost-effective treatment option for severe tubal factors and endometriosis, with surgery the most cost-effective in the case of mild or moderate disease. Ovulatory factors should be treated medically with the addition of laparoscopic ovarian diathermy in the presence of polycystic ovarian syndrome. For other causes, stimulated intrauterine insemination (unexplained and moderate male factor) and stimulated donor intrauterine insemination (severe male) are cost-effective.

My notes (saved in your browser only)

Condition tags

endometriosisinfertility

MeSH descriptors

Cost-Benefit Analysis Cost-Benefit Analysis Reproductive Techniques Diathermy Diathermy Fallopian Tube Diseases Fallopian Tube Diseases Fallopian Tube Diseases Female Female Fertilization in Vitro Fertilization in Vitro Fertilization in Vitro Humans Humans Infertility Infertility Infertility Infertility Infertility

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (28)

Cited by (14)

Source provenance

europepmc
last seen: 2026-10-24T06:12:55.650802+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T20:59:14.592962+00:00
unpaywall
last seen: 2026-10-24T06:30:43.844863+00:00
License: CC0 · commercial use OK